Micro guide catheters market is anticipated to grow at a significant CAGR of 7.0% during the forecast period (2024-2031).  The market growth is attributed to the increasing demand for minimally invasive surgeries, catheters medical device adoption in urological, ophthalmic, gastrointestinal, neurovascular, and cardiovascular procedures drives the market growth. Micro guide catheters are specialized medical devices that help other equipment, such as wires and balloons, navigate through the intricate circulatory system during minimally invasive treatments. These catheters are made to enhance control and precision during treatments, which will ultimately benefit the patient. According to the International Society for Infectious Diseases, in June 2021, Catheter-associated urinary tract infections (CAUTI) are one of the most common healthcare-associated infections (HAI). The frequency of CAUTI is 12.9%, 19.6%, and 24% in the US, Europe, and developing countries, respectively.

Market Dynamics

Growing Micro Guide Catheters Use in Electronic Devices to Protect Screens from UV Damage

In recent years, ultraviolet filters have been found in several electronic devices, including laptops and smartphones. These filters are intended to shield screens from UV radiation's damaging effects. Radiation, which is found in sunshine and other light sources, can harm a screen over time, leading to problems such as color distortion and decreased visibility. Micro Guide Catheters function by letting visible light through while preventing dangerous UV rays. This prolongs the device's life and lowers the possibility of screen damage. While some electronic devices have Micro Guide Catheters built right in, others require users to buy additional filters to stick on the screen.

Encapsulating Techniques Integration in Sunscreens to Improve Efficacy and Safety

The encapsulating techniques are already employed in numerous commercially available formulations, including methacrylate polymers (PMMA), the encapsulation techniques offer innovative, safe, and environmentally friendly sunscreens. By utilizing organic and inorganic filters, one can guard against the impacts of infrared radiation, as well as UV and visible light. Skin photoaging has long been linked to near-infrared light, or NIR. The researcher measured the UVA protection factor in vitro according to ISO guidelines, and the results demonstrated the high level of efficacy of tinted sunscreens against UV and visible radiation. The average transmittance of radiation in the 760–1300 nm region is reduced by 40.0–50.0% due to their absorption spectra, which reach wavelengths up to 1300 nm.

Market Segmentation

• Based on the type, the market is segmented over the wire, and flow-directed.

• Based on the indication, the market is segmented into cardiovascular, neurovascular, urology, and others.

• Based on the end-users, the market is segmented into hospitals, specialty clinics, and ambulatory surgical centers.

Cardiovascular is Projected to Hold the Largest Segment

The primary factors supporting the growth include increasing demand for cardiac catheterization for diagnosing heart attacks. The coronary arteries are made apparent on X-ray images during the process by injecting contrast dye into them. Doctors are then able to assess the best course of action by precisely locating and measuring the blockage. Precision Diagnosis Doctors can accurately diagnose the location and severity of blockages in the coronary arteries that feed blood to the heart with cardiac catheterization, a reliable diagnostic tool. The precise location of the blockage and the extent of the heart muscle damage can be ascertained by medical professionals by using X-ray imaging. For instance, in May 2024, Medtronic plc announced positive results demonstrating excellent safety and efficacy of the Affera mapping and ablation system with sphere-9 catheter, an all-in-one pulsed field (PF) and radiofrequency (RF) ablation and high-density (HD) mapping catheter for the treatment of persistent atrial fibrillation (AFib).

Hospital Segment to Hold a Considerable Market Share

Hospitals frequently employ micro-guide catheters for a range of medical operations and thus hold the major share of the global market. Micro-guide catheters are used in hospitals for operations related to cardiology and interventional radiology. These catheters are used in hospitals for cancer treatments and neurovascular procedures. Micro-guide catheters are used in hospitals for endovascular therapy and other minimally invasive procedures. The accuracy and portability of microguide catheters in administering treatments to patients is advantageous to these healthcare facilities. According to the Centers for Disease Control and Prevention (CDC), in January 2024, approximately 12.0%-16.0% of adult hospital inpatients will have an indwelling urinary catheter (IUC) at some time during their hospitalization, and each day the indwelling urinary catheter remains, a patient has a 3.0%-7.0% increased risk of acquiring a catheter-associated urinary tract infection (CAUTI). UTIs additionally account for more than 9.5% of infections reported by acute care hospitals. Virtually, all healthcare-associated Urinary tract infections (UTIs) are caused by instrumentation of the urinary tract.   

Regional Outlook

The global micro guide catheters market is further segmented based on geography including North America (the US, and Canada), Europe (the UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America). 

Growing Demand for Micro Guide Catheters in Europe

• The regional growth is attributed to the growing urinary incontinence and other urological disorders, and developments in the field of catheter technology with increasing demand for less intrusive medical treatments. According to the European Association of Urology, in September 2021, urinary incontinence (UI) is a common issue affecting 10.0% to 20.0% of people across Europe. The highest number of unawareness of treatment is in the UK, with 47.0% not knowing about treatment possibilities. In Italy, 46.0% of the respondents said they are not seeing a specialist as they expect UI to improve by itself, followed by the Netherlands (38.0%), the UK (35.0%), Germany (33.0%), and France (32.0%).

Global Micro Guide Catheters Market Growth by Region 2024-2031

North America Holds Major Market Share

North America holds a significant share owing to the number of regional companies in the micro guide catheter market, including Becton Dickinson and Co., Stryker Corp., Cardinal Health, Inc., and others. The market growth is attributed to the increase in the prevalence of cardiovascular diseases, urinary incontinence, and other chronic diseases, and the subsequent increase in the number of patients across the region. According to the American College of Surgeons, more than 5.0 million central venous catheters (CVCs) are placed each year in the US, with an associated complication rate of more than 15.0%.  Mechanical complications such as arterial puncture and pneumothorax are seen in up to 21.0% of patients with CVC complications, and up to 35.0% of insertion, attempts are not successful. Removing the needle from blood draws and reducing IV replacements, may reduce the risk of needlestick injury and blood exposure for clinicians while preserving a patient's vessel health. For instance, in November 2023, BD (Becton, Dickinson and Company, a medical technology company, introduced a new needle-free blood draw technology compatible with integrated catheters, helping to further enable the company's vision of a "One-Stick Hospital Stay."  With 510(k) clearance from the US Food and Drug Administration (FDA), the new PIVO Pro needle-free blood collection device features design improvements to achieve the first and only compatibility with integrated and long peripheral IV catheters, including the new Nexiva Closed IV Catheter System with NearPort IV Access.

Market Players Outlook

*Note: Major Players Sorted in No Particular Order.

The major companies serving the micro guide catheters market include B. Braun Melsungen AG, Becton Dickinson and Co., Cardinal Health, Inc., Medtronic PLC, and Terumo Medical Corp. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market. 

Recent Development

• In June 2024, B. Braun Interventional Systems Inc. (BIS), a member of the B. Braun Group of Companies, introduced its new ACCEL All-Purpose and Biliary Drainage Catheters with TrueGlide Hydrophilic Coating for percutaneous drainage.

The Report Covers

• Market value data analysis of 2023 and forecast to 2031.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the micro guide catheters market. Based on the availability of data, information related to new products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.